Clinical Trial

Cannabis Effects on Opioid Self-Administration

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The study will enroll participants with opioid use disorder and participants will reside at the University of Kentucky Hospital for this 6-week inpatient trial. During this time, double-blind doses of cannabis and opioids will be administered. The goal of the project is to determine if cannabis can alter the drive/desire to take opioids.
Trial Details
NCT Number NCT07668635
Lead Sponsor Shanna Babalonis, PhD
Conditions Opioid Use Disorder, Cannabis Use
Enrollment 30 participants
Start Date 2026-07-30
Primary Completion 2030-07-30 (estimated)
Study Completion 2031-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-25